Non-Woven Sheet Containing Gemcitabine: Controlled Release Complex for Pancreatic Cancer Treatment
The 5-year survival rate for pancreatic cancer remains low, and the development of new methods for its treatment is actively underway. After the surgical treatment of pancreatic cancer, recurrence and peritoneal dissemination can be prevented by long-term local exposure to appropriate drug concentra...
Gespeichert in:
Veröffentlicht in: | Polymers 2022-01, Vol.14 (1), p.168 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 1 |
container_start_page | 168 |
container_title | Polymers |
container_volume | 14 |
creator | Sakura, Kazuma Sasai, Masao Mino, Takayuki Uyama, Hiroshi |
description | The 5-year survival rate for pancreatic cancer remains low, and the development of new methods for its treatment is actively underway. After the surgical treatment of pancreatic cancer, recurrence and peritoneal dissemination can be prevented by long-term local exposure to appropriate drug concentrations. We propose a novel treatment method using non-woven sheets to achieve this goal. Poly(L-lactic acid) non-woven sheets containing gemcitabine (GEM) were prepared, and GEM sustained release from this delivery system was investigated. Approximately 35% of the GEM dose was released within 30 d. For in vitro evaluation, we conducted a cell growth inhibition test using transwell assays, and significant inhibition of cell growth was observed. The antitumor effects of subcutaneously implanted GEM-containing non-woven sheets were evaluated in mice bearing subcutaneous Panc02 cells, and it was established that the sheets inhibited tumor growth for approximately 28 d. These results suggest the usefulness of GEM-containing non-woven sheets in pancreatic cancer treatment. |
doi_str_mv | 10.3390/polym14010168 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8747259</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2618267453</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-1713ff0abbe1acb1744842bd4a1ace242916d5d09035d04de9645a31af8fa2bf3</originalsourceid><addsrcrecordid>eNpdkUtLxTAQhYMoKurSrRTcuKlmkrRpXQhy8QWi4gOXIW2nGkmTa9Ir3n9vfKJmMZnHx0mGQ8gm0F3Oa7o39XY-gKBAoawWyCqjkueCl3TxV75CNmJ8oumIoixBLpMVXlBgUNNV0lx4l9_7F3TZzSPimE28G7Vxxj1kJzi0ZtSNcbj_0Q_eWuyya7SoI6bWMLX4mvU-ZFfatQH1aNpsklIM2e17OaAb18lSr23Eja97jdwdH91OTvPzy5OzyeF53gooxhwk8L6numkQdNuAFKISrOmETiUywWoou6KjNeUpig7rUhSag-6rXrOm52vk4FN3OmsG7Nr0dNBWTYMZdJgrr436O3HmUT34F1VJIVlRJ4GdL4Hgn2cYRzWY2KK12qGfRcVKqGoQQsqEbv9Dn_wsuLTeB8VKKQqeqPyTaoOPMWD_8xmg6t1A9cfAxG_93uCH_raLvwHWIJg6</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2618267453</pqid></control><display><type>article</type><title>Non-Woven Sheet Containing Gemcitabine: Controlled Release Complex for Pancreatic Cancer Treatment</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Free E-Journal (出版社公開部分のみ)</source><source>PubMed</source><source>PubMed Central Open Access</source><creator>Sakura, Kazuma ; Sasai, Masao ; Mino, Takayuki ; Uyama, Hiroshi</creator><creatorcontrib>Sakura, Kazuma ; Sasai, Masao ; Mino, Takayuki ; Uyama, Hiroshi</creatorcontrib><description>The 5-year survival rate for pancreatic cancer remains low, and the development of new methods for its treatment is actively underway. After the surgical treatment of pancreatic cancer, recurrence and peritoneal dissemination can be prevented by long-term local exposure to appropriate drug concentrations. We propose a novel treatment method using non-woven sheets to achieve this goal. Poly(L-lactic acid) non-woven sheets containing gemcitabine (GEM) were prepared, and GEM sustained release from this delivery system was investigated. Approximately 35% of the GEM dose was released within 30 d. For in vitro evaluation, we conducted a cell growth inhibition test using transwell assays, and significant inhibition of cell growth was observed. The antitumor effects of subcutaneously implanted GEM-containing non-woven sheets were evaluated in mice bearing subcutaneous Panc02 cells, and it was established that the sheets inhibited tumor growth for approximately 28 d. These results suggest the usefulness of GEM-containing non-woven sheets in pancreatic cancer treatment.</description><identifier>ISSN: 2073-4360</identifier><identifier>EISSN: 2073-4360</identifier><identifier>DOI: 10.3390/polym14010168</identifier><identifier>PMID: 35012190</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Anticancer properties ; Cancer ; Cancer therapies ; Catheters ; Cell cycle ; Cell division ; Chemotherapy ; Controlled release ; Cytotoxicity ; Experiments ; Medical prognosis ; Metastasis ; Pancreatic cancer ; Polylactic acid ; Sheets ; Sustained release</subject><ispartof>Polymers, 2022-01, Vol.14 (1), p.168</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-1713ff0abbe1acb1744842bd4a1ace242916d5d09035d04de9645a31af8fa2bf3</citedby><cites>FETCH-LOGICAL-c415t-1713ff0abbe1acb1744842bd4a1ace242916d5d09035d04de9645a31af8fa2bf3</cites><orcidid>0000-0002-8587-2507</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747259/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747259/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35012190$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sakura, Kazuma</creatorcontrib><creatorcontrib>Sasai, Masao</creatorcontrib><creatorcontrib>Mino, Takayuki</creatorcontrib><creatorcontrib>Uyama, Hiroshi</creatorcontrib><title>Non-Woven Sheet Containing Gemcitabine: Controlled Release Complex for Pancreatic Cancer Treatment</title><title>Polymers</title><addtitle>Polymers (Basel)</addtitle><description>The 5-year survival rate for pancreatic cancer remains low, and the development of new methods for its treatment is actively underway. After the surgical treatment of pancreatic cancer, recurrence and peritoneal dissemination can be prevented by long-term local exposure to appropriate drug concentrations. We propose a novel treatment method using non-woven sheets to achieve this goal. Poly(L-lactic acid) non-woven sheets containing gemcitabine (GEM) were prepared, and GEM sustained release from this delivery system was investigated. Approximately 35% of the GEM dose was released within 30 d. For in vitro evaluation, we conducted a cell growth inhibition test using transwell assays, and significant inhibition of cell growth was observed. The antitumor effects of subcutaneously implanted GEM-containing non-woven sheets were evaluated in mice bearing subcutaneous Panc02 cells, and it was established that the sheets inhibited tumor growth for approximately 28 d. These results suggest the usefulness of GEM-containing non-woven sheets in pancreatic cancer treatment.</description><subject>Anticancer properties</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Catheters</subject><subject>Cell cycle</subject><subject>Cell division</subject><subject>Chemotherapy</subject><subject>Controlled release</subject><subject>Cytotoxicity</subject><subject>Experiments</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>Pancreatic cancer</subject><subject>Polylactic acid</subject><subject>Sheets</subject><subject>Sustained release</subject><issn>2073-4360</issn><issn>2073-4360</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkUtLxTAQhYMoKurSrRTcuKlmkrRpXQhy8QWi4gOXIW2nGkmTa9Ir3n9vfKJmMZnHx0mGQ8gm0F3Oa7o39XY-gKBAoawWyCqjkueCl3TxV75CNmJ8oumIoixBLpMVXlBgUNNV0lx4l9_7F3TZzSPimE28G7Vxxj1kJzi0ZtSNcbj_0Q_eWuyya7SoI6bWMLX4mvU-ZFfatQH1aNpsklIM2e17OaAb18lSr23Eja97jdwdH91OTvPzy5OzyeF53gooxhwk8L6numkQdNuAFKISrOmETiUywWoou6KjNeUpig7rUhSag-6rXrOm52vk4FN3OmsG7Nr0dNBWTYMZdJgrr436O3HmUT34F1VJIVlRJ4GdL4Hgn2cYRzWY2KK12qGfRcVKqGoQQsqEbv9Dn_wsuLTeB8VKKQqeqPyTaoOPMWD_8xmg6t1A9cfAxG_93uCH_raLvwHWIJg6</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Sakura, Kazuma</creator><creator>Sasai, Masao</creator><creator>Mino, Takayuki</creator><creator>Uyama, Hiroshi</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>HCIFZ</scope><scope>JG9</scope><scope>KB.</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8587-2507</orcidid></search><sort><creationdate>20220101</creationdate><title>Non-Woven Sheet Containing Gemcitabine: Controlled Release Complex for Pancreatic Cancer Treatment</title><author>Sakura, Kazuma ; Sasai, Masao ; Mino, Takayuki ; Uyama, Hiroshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-1713ff0abbe1acb1744842bd4a1ace242916d5d09035d04de9645a31af8fa2bf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anticancer properties</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Catheters</topic><topic>Cell cycle</topic><topic>Cell division</topic><topic>Chemotherapy</topic><topic>Controlled release</topic><topic>Cytotoxicity</topic><topic>Experiments</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>Pancreatic cancer</topic><topic>Polylactic acid</topic><topic>Sheets</topic><topic>Sustained release</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sakura, Kazuma</creatorcontrib><creatorcontrib>Sasai, Masao</creatorcontrib><creatorcontrib>Mino, Takayuki</creatorcontrib><creatorcontrib>Uyama, Hiroshi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>SciTech Premium Collection</collection><collection>Materials Research Database</collection><collection>https://resources.nclive.org/materials</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Polymers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sakura, Kazuma</au><au>Sasai, Masao</au><au>Mino, Takayuki</au><au>Uyama, Hiroshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non-Woven Sheet Containing Gemcitabine: Controlled Release Complex for Pancreatic Cancer Treatment</atitle><jtitle>Polymers</jtitle><addtitle>Polymers (Basel)</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>14</volume><issue>1</issue><spage>168</spage><pages>168-</pages><issn>2073-4360</issn><eissn>2073-4360</eissn><abstract>The 5-year survival rate for pancreatic cancer remains low, and the development of new methods for its treatment is actively underway. After the surgical treatment of pancreatic cancer, recurrence and peritoneal dissemination can be prevented by long-term local exposure to appropriate drug concentrations. We propose a novel treatment method using non-woven sheets to achieve this goal. Poly(L-lactic acid) non-woven sheets containing gemcitabine (GEM) were prepared, and GEM sustained release from this delivery system was investigated. Approximately 35% of the GEM dose was released within 30 d. For in vitro evaluation, we conducted a cell growth inhibition test using transwell assays, and significant inhibition of cell growth was observed. The antitumor effects of subcutaneously implanted GEM-containing non-woven sheets were evaluated in mice bearing subcutaneous Panc02 cells, and it was established that the sheets inhibited tumor growth for approximately 28 d. These results suggest the usefulness of GEM-containing non-woven sheets in pancreatic cancer treatment.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35012190</pmid><doi>10.3390/polym14010168</doi><orcidid>https://orcid.org/0000-0002-8587-2507</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2073-4360 |
ispartof | Polymers, 2022-01, Vol.14 (1), p.168 |
issn | 2073-4360 2073-4360 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8747259 |
source | MDPI - Multidisciplinary Digital Publishing Institute; Free E-Journal (出版社公開部分のみ); PubMed; PubMed Central Open Access |
subjects | Anticancer properties Cancer Cancer therapies Catheters Cell cycle Cell division Chemotherapy Controlled release Cytotoxicity Experiments Medical prognosis Metastasis Pancreatic cancer Polylactic acid Sheets Sustained release |
title | Non-Woven Sheet Containing Gemcitabine: Controlled Release Complex for Pancreatic Cancer Treatment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T07%3A13%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non-Woven%20Sheet%20Containing%20Gemcitabine:%20Controlled%20Release%20Complex%20for%20Pancreatic%20Cancer%20Treatment&rft.jtitle=Polymers&rft.au=Sakura,%20Kazuma&rft.date=2022-01-01&rft.volume=14&rft.issue=1&rft.spage=168&rft.pages=168-&rft.issn=2073-4360&rft.eissn=2073-4360&rft_id=info:doi/10.3390/polym14010168&rft_dat=%3Cproquest_pubme%3E2618267453%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2618267453&rft_id=info:pmid/35012190&rfr_iscdi=true |